| PERIOD ENDING | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
|
-
| | Cost of Revenue |
-
|
-
| | | Gross Profit |
-
|
-
| | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 555 | 504 | | Non Recurring | 250 | 88 | | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (805) | (593) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (200) |
-
| | Earnings Before Interest And Taxes | (1,005) | (593) | | Interest Expense | 5 |
-
| | Income Before Tax | (1,010) | (593) | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (1,010) | (593) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (1,010) | (593) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($1,010) | ($593) |
|
0.20% Nasdaq 
Income Statement
